Skip to content
Screener

Citius Oncology, Inc. CTOR Q4 2025 Annual earnings

Reported December 23, 2025 · Before market open

EPS-$0.06In line
EPS estimate-$0.06

Next report

Date not yet announced

Financials

Q4 2025

Income statement

See full
Operating income-$4.7M+29.4%
Net income-$5.0M+26.7%
EPS (diluted)-$0.06+40.0%

Balance sheet

See full
Cash & equivalents$3.9M+3,504,282%
Total equity$44.9M-2.8%
Total assets$100.9M+19.6%

Cash flow

See full
Operating cash flow-$1.4M-301%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$169.53M—

Returns & leverage

See full
Return on equity-54.4%-3.9pp
Current ratio0.6×+0.2×

FAQ

When did Citius Oncology, Inc. report Q4 2025 earnings?
Citius Oncology, Inc. (CTOR) reported Q4 2025 earnings on December 23, 2025 before market open.
What were Citius Oncology, Inc.'s Q4 2025 revenue and EPS?
Citius Oncology, Inc. reported eps of $-0.06 for Q4 2025.
Did Citius Oncology, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.06 by $0.00.
How did Citius Oncology, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 33.3% from $-0.09.
Where can I find Citius Oncology, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-125418) and the 10-K periodic report (0001213900-25-125331) directly on SEC EDGAR. The filing index links above go to sec.gov.